Deprescribing proton pump inhibitors: Evidence-based clinical practice guideline

In particular, the tokens of the user-generated content -after some pre-processing of the words, which includes removal of stop-words and non- English words, stemming, and

SHRN aims to: 1) provide health and well-being data from a biennial survey for national, regional and local stakeholders, including schools; 2) co-produce school-based health

This scoping review aims to support a more consistent approach to workforce development in the UK, by identifying and mapping the current evidence base underpinning

Background and Purpose: In 2014, a multidisciplinary breast cancer group developed and disseminated a clinical practice guideline to assist surgeons in choosing eligible patients,

Organizational performance may be improved most when performance evaluation practices do include both administrative activities and developmental review sessions and

Patients should understand: • The rationale for deprescribing (associated risks of continued BZRA use, reduced long-term efficacy) • Withdrawal symptoms (insomnia, anxiety) may

Evidence was generated from a Cochrane systematic review of antipsychotic deprescribing trials for the behavioural and psychological symptoms of dementia, and a systematic review was